您的位置：首页 > 产品中心 > 303-26-4， 西替利嗪杂质A
西替利嗪杂质A
Cetirizine impurity A
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 3424514 | 1400 |
产品别名
303-26-4
西替利嗪杂质A
Cetirizine impurity A
(RS)-1-[(4-Chlorophenyl)phenylmethyl]piperazine
1-(4-Chlorobenzhydryl)piperazine
NSC 86164
Norchlorcyclizine
(RS)-1-[(4-氯苯基)苯基甲基]哌嗪
1-(4-氯二苯甲基)哌嗪
西替利嗪
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C17H19ClN2 |
| Molecular weight | 286.80 |
| MDL number | MFCD00005965 |
| PubChem Substance ID【PubChem化学物质编号】 | 329774832 |
| NACRES | NA.24 |
| General description【一般描述】 | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. |
| Caution【注意】 | Please find SDS provided by EDQM here.. |
| Other Notes【其他说明】 | Sales restrictions may apply. |
产品性质
| grade【等级】 | pharmaceutical primary standard |
| manufacturer/tradename | EDQM |
| bp | 178-180 ℃/0.5 mmHg (lit.) |
| mp | 65-70 ℃ (lit.) |
| application(s) | pharmaceutical (small molecule) |
| format【格式】 | neat |
| SMILES string | Clc1ccc(cc1)C(N2CCNCC2)c3ccccc3 |
| InChI | 1S/C17H19ClN2/c18-16-8-6-15(7-9-16)17(14-4-2-1-3-5-14)20-12-10-19-11-13-20/h1-9,17,19H,10-13H2 |
| InChI key | UZKBSZSTDQSMDR-UHFFFAOYSA-N |
| packaging【包装】 | Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. |
安全信息
| Pictograms【象形图】 | GHS05,GHS07,GHS08 |
| Signal word【警示用语：】 | Danger |
| Hazard Statements | H315 - H317 - H318 - H361fd |
| Precautionary Statements | P201 - P202 - P280 - P302 + P352 - P305 + P351 + P338 - P308 + P313 |
| Hazard Classifications【危险分类】 | Eye Dam. 1 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1 |
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
